David G. Standaert, M.D., Ph.D. - Related publications

Affiliations: 
Neurology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Parkinson's disease
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2021 Lee S, Suh YJ, Lee Y, Yang S, Hong DG, Thirumalai D, Chang SC, Chung KW, Jung YS, Moon HR, Chung HY, Lee J. Anti-Inflammatory Effects of the Novel Barbiturate Derivative MHY2699 in an MPTP-Induced Mouse Model of Parkinson's Disease. Antioxidants (Basel, Switzerland). 10. PMID 34829726 DOI: 10.3390/antiox10111855   
2021 Karimi A, Elmi M, Shiri Z, Baharvand H. Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson's disease: a systematic review protocol. Systematic Reviews. 10: 188. PMID 34172098 DOI: 10.1186/s13643-021-01736-z   
2021 Mirzaei S, Kulkarni K, Zhou K, Crack PJ, Aguilar MI, Finkelstein DI, Forsythe JS. Biomaterial Strategies for Restorative Therapies in Parkinson's Disease. Acs Chemical Neuroscience. PMID 34634903 DOI: 10.1021/acschemneuro.1c00484   
2021 Toyoshima Y, Takahashi H, Katada S, Kojima N, Tada M, Tani T, Koike R, Nozawa T, Aida I, Nakajima T, Onodera O, Kakita A. Parkinson's disease and parkinsonism: Clinicopathological discrepancies on diagnosis in three patients. Neuropathology : Official Journal of the Japanese Society of Neuropathology. PMID 34779072 DOI: 10.1111/neup.12777   
2021 Ferrer-Lorente R, Lozano-Cruz T, Fernández-Carasa I, Miłowska K, de la Mata FJ, Bryszewska M, Consiglio A, Ortega P, Gómez R, Raya A. Cationic Carbosilane Dendrimers Prevent Abnormal α-Synuclein Accumulation in Parkinson's Disease Patient-Specific Dopamine Neurons. Biomacromolecules. 22: 4582-4591. PMID 34613701 DOI: 10.1021/acs.biomac.1c00884   
2021 Oh T, Daadi ES, Kim J, Daadi EW, Chen PJ, Roy-Choudhury G, Bohmann J, Blass BE, Daadi MM. Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease. Experimental Neurology. 113920. PMID 34762921 DOI: 10.1016/j.expneurol.2021.113920   
2021 Tian Y, He M, Pan L, Yuan X, Xiong M, Meng L, Yao Z, Yu Z, Ye K, Zhang Z. Transgenic Mice Expressing Human α-Synuclein 1-103 Fragment as a Novel Model of Parkinson's Disease. Frontiers in Aging Neuroscience. 13: 760781. PMID 34744697 DOI: 10.3389/fnagi.2021.760781   
2021 Hsu YL, Hung HS, Tsai CW, Liu SP, Chiang YT, Kuo YH, Shyu WC, Lin SZ, Fu RH. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro. International Journal of Molecular Sciences. 22. PMID 34638579 DOI: 10.3390/ijms221910240   
2021 Lima IS, Pêgo AC, Barros JT, Prada AR, Gozzelino R. Cell Death-Osis of Dopaminergic Neurons and the Role of Iron in Parkinson's Disease. Antioxidants & Redox Signaling. 35: 453-473. PMID 33233941 DOI: 10.1089/ars.2020.8229   
2021 Christmann A, Gries M, Scholz P, Stahr PL, Law JKY, Schulte S, Martin M, Lilischkis R, Ingebrandt S, Keck CM, Schäfer KH. The antioxidant Rutin counteracts the pathological impact of -synuclein on the enteric nervous system . Biological Chemistry. PMID 34582634 DOI: 10.1515/hsz-2021-0259   
2021 Zhou Z, Ye P, Li XH, Zhang Y, Li M, Chen QY, Lu JS, Xue M, Li Y, Liu W, Lu L, Shi W, Xu PY, Zhuo M. Synaptic potentiation of anterior cingulate cortex contributes to chronic pain of Parkinson's disease. Molecular Brain. 14: 161. PMID 34742316 DOI: 10.1186/s13041-021-00870-y   
2021 de Rus Jacquet A, Ambaw A, Tambe MA, Ma SY, Timmers M, Grace MH, Wu QL, Simon JE, McCabe GP, Lila MA, Shi R, Rochet JC. Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson's disease models. Food & Function. PMID 34751296 DOI: 10.1039/d1fo00007a   
2021 Hang L, Wang Z, Foo ASC, Goh GWY, Choong HC, Thundyil J, Xu S, Lam KP, Lim KL. Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo. Neurobiology of Disease. 161: 105560. PMID 34767944 DOI: 10.1016/j.nbd.2021.105560   
2021 González-Rodríguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA, Wokosin DL, Gao L, Kaplitt MG, López-Barneo J, Schumacker PT, Surmeier DJ. Disruption of mitochondrial complex I induces progressive parkinsonism. Nature. PMID 34732887 DOI: 10.1038/s41586-021-04059-0   
2021 Caulfield ME, Stancati JA, Steece-Collier K. Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease. Journal of Visualized Experiments : Jove. PMID 34723950 DOI: 10.3791/62970   
2021 Johnson AM, Ou ZA, Gordon R, Saminathan H. Environmental neurotoxicants and inflammasome activation in Parkinson's disease - a focus on the gut-brain axis. The International Journal of Biochemistry & Cell Biology. 106113. PMID 34737076 DOI: 10.1016/j.biocel.2021.106113   
2021 Hsiao IT, Chang YT, Weng YH, Hsu SW, Lin KJ, Lu CS, Chang CC. Comparisons of vesicular monoamine transporter type 2 signals in Parkinson's disease and Parkinsonism secondary to carbon monoxide poisoning. Neurotoxicology. PMID 34774656 DOI: 10.1016/j.neuro.2021.11.004   
2021 Cai P, Zheng Y, Sun Y, Zhang C, Zhang Q, Liu Q. New Blood-Brain Barrier Models Using Primary Parkinson's Disease Rat Brain Endothelial Cells and Astrocytes for the Development of Central Nervous System Drug Delivery Systems. Acs Chemical Neuroscience. PMID 34623131 DOI: 10.1021/acschemneuro.1c00118   
2021 Harris KL, Mason SL, Vallin B, Barker RA. Reduced expression of dopamine D2 receptors on astrocytes in R6/1 HD mice and HD post-mortem tissue. Neuroscience Letters. 136289. PMID 34637857 DOI: 10.1016/j.neulet.2021.136289   
2021 Chetia Phukan B, Dutta A, Deb S, Saikia R, Mazumder MK, Paul R, Bhattacharya P, Sandhir R, Borah A. Garcinol blocks motor behavioural deficits by providing dopaminergic neuroprotection in MPTP mouse model of Parkinson's disease: involvement of anti-inflammatory response. Experimental Brain Research. PMID 34633467 DOI: 10.1007/s00221-021-06237-y   
2021 Ahmad J, Haider N, Khan MA, Md S, Alhakamy NA, Ghoneim MM, Alshehri S, Sarim Imam S, Ahmad MZ, Mishra A. Novel Therapeutic Interventions for Combating Parkinson's Disease and Prospects of Nose-to-Brain Drug Delivery. Biochemical Pharmacology. 114849. PMID 34808125 DOI: 10.1016/j.bcp.2021.114849   
2021 Kiran P, Debnath SK, Neekhra S, Pawar V, Khan A, Dias F, Pallod S, Srivastava R. Designing nanoformulation for the nose-to-brain delivery in Parkinson's disease: Advancements and barrier. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. e1768. PMID 34825510 DOI: 10.1002/wnan.1768   
2021 Higgins AL, Toffoli M, Mullin S, Lee CY, Koletsi S, Avenali M, Blandini F, Schapira AH. The remote assessment of parkinsonism supporting ongoing development of interventions in Gaucher disease. Neurodegenerative Disease Management. PMID 34666501 DOI: 10.2217/nmt-2021-0032   
2021 Moni MMR, Begum MM, Uddin MS, Ashraf GM. Deciphering the Role of Nanoparticle-based Treatment for Parkinson's Disease. Current Drug Metabolism. 22: 550-560. PMID 33530903 DOI: 10.2174/1389200222666210202110129   
2021 Nam MH, Park JH, Song HJ, Choi JW, Kim S, Jang BK, Yoon HH, Heo JY, Lee H, An H, Kim HJ, Park SJ, Cho DW, Yang YS, Han SC, et al. KDS2010, a Newly Developed Reversible MAO-B Inhibitor, as an Effective Therapeutic Candidate for Parkinson's Disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. PMID 34611843 DOI: 10.1007/s13311-021-01097-4   
2021 Lan G, Wang P, Chan RB, Liu Z, Yu Z, Liu X, Yang Y, Zhang J. Astrocytic VEGFA: An essential mediator in blood-brain-barrier disruption in Parkinson's disease. Glia. PMID 34713920 DOI: 10.1002/glia.24109   
2021 Zhang X, Chen W, Wu Y, Zeng W, Yuan Y, Cheng C, Yang X, Wang J, Yang X, Xu Y, Lei H, Cao X, Xu Y. Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry. Frontiers in Aging Neuroscience. 13: 759934. PMID 34776935 DOI: 10.3389/fnagi.2021.759934   
2021 Hacker M, Cannard G, Turchan M, Meystedt J, Davis T, Phibbs F, Hedera P, Konrad P, Charles D. Early subthalamic nucleus deep brain stimulation in Parkinson's disease reduces long-term medication costs. Clinical Neurology and Neurosurgery. 210: 106976. PMID 34666273 DOI: 10.1016/j.clineuro.2021.106976   
2021 Zhang M, Wang H, Xue L, Yang X. [Advances in fecal microbiota transplantation for treatment of Parkinson's disease]. Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology. 37: 3812-3819. PMID 34841786 DOI: 10.13345/j.cjb.200770   
2021 Cai HY, Fu XX, Jiang H, Han S. Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease. Npj Parkinson's Disease. 7: 91. PMID 34625569 DOI: 10.1038/s41531-021-00233-3   
2021 Yan Y, Chen Y, Liu Z, Cai F, Niu W, Song L, Liang H, Su Z, Yu B, Yan F. Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood-Brain Barrier Opening via Lipid-PLGA Nanobubbles. International Journal of Nanomedicine. 16: 7433-7447. PMID 34764649 DOI: 10.2147/IJN.S327737   
2021 Esteves AR, Munoz-Pinto MF, Nunes-Costa D, Candeias E, Silva DF, Magalhães JD, Pereira-Santos AR, Ferreira IL, Alarico S, Tiago I, Empadinhas N, Cardoso SM. Footprints of a microbial toxin from the gut microbiome to mesencephalic mitochondria. Gut. PMID 34836918 DOI: 10.1136/gutjnl-2021-326023   
2021 Kim AR, Pavlova EN, Blokhin VE, Bogdanov VV, Ugrumov MV. A Monoiodotyrosine Challenge Test in a Parkinson's Disease Model. Acta Naturae. 13: 106-109. PMID 34707902 DOI: 10.32607/actanaturae.11399   
2021 Toh TS, Chong CW, Lim SY, Bowman J, Cirstea M, Lin CH, Chen CC, Appel-Cresswell S, Finlay BB, Tan AH. Gut microbiome in Parkinson's disease: New insights from meta-analysis. Parkinsonism & Related Disorders. 94: 1-9. PMID 34844021 DOI: 10.1016/j.parkreldis.2021.11.017   
2021 Karabayir I, Butler L, Goldman SM, Kamaleswaran R, Gunturkun F, Davis RL, Ross GW, Petrovitch H, Masaki K, Tanner CM, Tsivgoulis G, Alexandrov AV, Chinthala LK, Akbilgic O. Predicting Parkinson's Disease and Its Pathology via Simple Clinical Variables. Journal of Parkinson's Disease. PMID 34602502 DOI: 10.3233/JPD-212876   
2021 Orso B, Arnaldi D, Girtler N, Brugnolo A, Doglione E, Mattioli P, Biassoni E, Fancellu R, Massa F, Bauckneht M, Chiola S, Morbelli S, Nobili F, Pardini M. Dopaminergic and Serotonergic Degeneration and Cortical [ F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. 36: 2293-2302. PMID 34021923 DOI: 10.1002/mds.28654   
2021 Pediaditakis I, Kodella KR, Manatakis DV, Le CY, Hinojosa CD, Tien-Street W, Manolakos ES, Vekrellis K, Hamilton GA, Ewart L, Rubin LL, Karalis K. Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption. Nature Communications. 12: 5907. PMID 34625559 DOI: 10.1038/s41467-021-26066-5   
2021 Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R. The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease. Redox Biology. 47: 102134. PMID 34600334 DOI: 10.1016/j.redox.2021.102134   
2021 Valli M, Cho SS, Uribe C, Masellis M, Chen R, Mihaescu A, Strafella AP. VMAT2 availability in Parkinson's disease with probable REM sleep behaviour disorder. Molecular Brain. 14: 165. PMID 34758845 DOI: 10.1186/s13041-021-00875-7   
2021 Laganas C, Iakovakis D, Hadjidimitriou SK, Charisis V, Dias SB, Bostanjopoulou S, Katsarou Z, Klingelhoefer L, Reichmann H, Trivedi D, Chaudhuri R, Hadjileontiadis LJ. Parkinson's Disease Detection Based on Running Speech Data From Phone Calls. Ieee Transactions On Bio-Medical Engineering. PMID 34596531 DOI: 10.1109/TBME.2021.3116935   
2021 Soner BC, Acikgoz E, Inan SY, Ayla S, Sahin AS, Oktem G. Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson's Disease in Rats. Parkinson's Disease. 2021: 5553480. PMID 34512945 DOI: 10.1155/2021/5553480   
2021 Giovannini D, Andreola F, Spitalieri P, Krasnowska EK, Colini Baldeschi A, Rossi S, Sangiuolo F, Cozzolino M, Serafino A. Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling. Cell Death Discovery. 7: 330. PMID 34725335 DOI: 10.1038/s41420-021-00723-6   
2021 Xu H, Zhong Y, Yuan S, Wu Y, Ma Z, Hao Z, Ding H, Wu H, Liu G, Pang M, Liu N, Wang C, Zhang N. Nitric Oxide Synthase Type 1 Methylation Is Associated With White Matter Microstructure in the Corpus Callosum and Greater Panic Disorder Severity Among Panic Disorder Patients. Frontiers in Neurology. 12: 755270. PMID 34733233 DOI: 10.3389/fneur.2021.755270   
2021 Xiong L, Pan JX, Guo HH, Mei L, Xiong WC. Parkinson's in the bone. Cell & Bioscience. 11: 190. PMID 34740382 DOI: 10.1186/s13578-021-00702-5   
2021 Yoon SY, Suh JH, Yang SN, Han K, Kim YW. Association of Physical Activity, Including Amount and Maintenance, With All-Cause Mortality in Parkinson Disease. Jama Neurology. PMID 34724534 DOI: 10.1001/jamaneurol.2021.3926   
2021 David FJ, Munoz MJ, Shils JL, Pauciulo MW, Hale PT, Nichols WC, Afshari M, Sani S, Verhagen Metman L, Corcos DM, Pal GD. Subthalamic Peak Beta Ratio Is Asymmetric in Glucocerebrosidase Mutation Carriers With Parkinson's Disease: A Pilot Study. Frontiers in Neurology. 12: 723476. PMID 34659089 DOI: 10.3389/fneur.2021.723476   
2021 Burbulla LF, Zheng J, Song P, Jiang W, Johnson ME, Brundin P, Krainc D. Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson's disease models. Jci Insight. 6. PMID 34622801 DOI: 10.1172/jci.insight.148649   
2021 Zhao Z, Li F, Ning J, Peng R, Shang J, Liu H, Shang M, Bao XQ, Zhang D. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4/MyD88/NF-B pathway through microbiota-gut-brain axis. Acta Pharmaceutica Sinica. B. 11: 2859-2879. PMID 34589401 DOI: 10.1016/j.apsb.2021.03.020   
2021 Ahmad MH, Fatima M, Ali M, Rizvi MA, Chandra Mondal A. Naringenin alleviates paraquat-induced dopaminergic neuronal loss in SH-SY5Y cells and a rat model of Parkinson's disease. Neuropharmacology. 108831. PMID 34655599 DOI: 10.1016/j.neuropharm.2021.108831   
2021 Mohammed M, Ivica N, Bjartmarz H, Thorbergsson PT, Pettersson LME, Thelin J, Schouenborg J. Microelectrode clusters enable therapeutic deep brain stimulation without noticeable side-effects in a rodent model of Parkinson's disease. Journal of Neuroscience Methods. 365: 109399. PMID 34695455 DOI: 10.1016/j.jneumeth.2021.109399